EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Sizing SGLT2 Inhibitors Up: From a Molecular to a Morpho-Functional Point of View

Silvia Prosperi, Andrea D'Amato, Paolo Severino iD, Vincenzo Myftari, Sara Monosilio, Ludovica Marchiori, Lucrezia Maria Zagordi, Domenico Filomena, Gianluca Di Pietro, Lucia Ilaria Birtolo, Roberto Badagliacca iD, Massimo Mancone und 2 weitere

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241813848 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Silvia Prosperi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical, Internal, Anesthesiology and Cardiovascular Sciences, Sapienza University of Rome, Viale del Policlinico, 155, 00161 Rome, It…. Hauptthemen laut MEDLINE: Sodium-Glucose Transporter 2 Inhibitors. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sodium–glucose cotransporter 2 inhibitors (SGLT2i), or gliflozins, have recently been shown to reduce cardiovascular death and hospitalization in patients with heart failure, representing a revolutionary therapeutic tool. The purpose of this review is to explore their multifaceted mechanisms of actions, beyond their known glucose reduction power. The cardioprotective effects of gliflozins seem to be linked to the maintenance of cellular homeostasis and to an action on the main metabolic pathways. They improve the oxygen supply for cardiomyocytes with a considerable impact on both functional and morphological myocardial aspects. Moreover, multiple molecular actions of SGLT2i are being discovered, such as the reduction of both inflammation, oxidative stress and cellular apoptosis, all responsible for myocardial damage. Various studies showed controversial results concerning the role of SGLT2i in reverse cardiac remodeling and the lowering of natriuretic peptides, suggesting that their overall effect has yet to be fully understood. In addition to this, advanced imaging studies evaluating the effect on all four cardiac chambers are lacking. Further studies will be needed to better understand the real impact of their administration, their use in daily practice and how they can contribute to benefits in terms of reverse cardiac remodeling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sodium-Glucose Transporter 2 InhibitorsHumansAnimalsSodium-Glucose Transporter 2Heart FailureDiabetes Mellitus, Type 2Myocytes, Cardiac

Stichwörter der Autor:innen

SGLT2icardiac reverse remodelingheart failure

Substanzen

Sodium-Glucose Transporter 2 InhibitorsSodium-Glucose Transporter 2

Autor:innen und Institutionen

  • Department of Clinical, Internal, Anesthesiology and Cardiovascular Sciences, Sapienza University of Rome, Viale del Policlinico, 155, 00161 Rome, Italy.

ORCID-Profile: Paolo Severino, Roberto Badagliacca, Viviana Maestrini, Carmine Dario Vizza

Zitieren

APA

Prosperi, S., D'Amato, A., Severino, P., Myftari, V., Monosilio, S., Marchiori, L., Zagordi, L. M., Filomena, D., Di Pietro, G., Birtolo, L. I., Badagliacca, R., Mancone, M., Maestrini, V., & Vizza, C. D. (2023). Sizing SGLT2 Inhibitors Up: From a Molecular to a Morpho-Functional Point of View. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241813848

Vancouver

Prosperi S, D'Amato A, Severino P, Myftari V, Monosilio S, Marchiori L, et al. Sizing SGLT2 Inhibitors Up: From a Molecular to a Morpho-Functional Point of View. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241813848

BibTeX
@article{Prosperi2023,
  author = {Prosperi, Silvia and D'Amato, Andrea and Severino, Paolo and Myftari, Vincenzo and Monosilio, Sara and Marchiori, Ludovica and Zagordi, Lucrezia Maria and Filomena, Domenico and Di Pietro, Gianluca and Birtolo, Lucia Ilaria and Badagliacca, Roberto and Mancone, Massimo and Maestrini, Viviana and Vizza, Carmine Dario},
  title = {Sizing SGLT2 Inhibitors Up: From a Molecular to a Morpho-Functional Point of View},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241813848}
}
Kostenlos starten →